Date | Name | Shares | Transaction | Value |
Apr 2, 2025
| Glenn David Jackola EVP & Chief Financial Officer |
17,371
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 2, 2025
| Glenn David Jackola EVP & Chief Financial Officer |
26,057
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 12, 2025
| Russell A. Becker President and CEO; Director |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 12, 2025
| Russell A. Becker President and CEO; Director |
1,414,796
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 12, 2025
| Russell A. Becker President and CEO; Director |
1,558,414
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 12, 2025
| Kristina Morton SVP and Chief People Officer |
51,468
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $36.28 per share |
1,867,259.04
|
Mar 12, 2025
| Russell A. Becker President and CEO; Director |
1,479,225
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $36.28 per share |
53,666,283.00
|
Mar 12, 2025
| Russell A. Becker President and CEO; Director |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 12, 2025
| Glenn David Jackola Interim CFO |
11,025
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 12, 2025
| Kristina Morton SVP and Chief People Officer |
63,589
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 12, 2025
| Kristina Morton SVP and Chief People Officer |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 12, 2025
| Glenn David Jackola Interim CFO |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 12, 2025
| Glenn David Jackola Interim CFO |
6,370
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 12, 2025
| Glenn David Jackola Interim CFO |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 6, 2025
| Ian Guy Handley Ashken Director |
5,765,988
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $38.55 per share |
222,278,837.40
|
Mar 6, 2025
| Ian Guy Handley Ashken Director |
5,834,803
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $37.42 per share |
218,338,328.26
|
Mar 6, 2025
| James E. Lillie Director |
1,069,259
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $37.43 per share |
40,022,364.37
|
Mar 6, 2025
| James E. Lillie Director |
5,380,958
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $37.43 per share |
201,409,257.94
|
Mar 6, 2025
| James E. Lillie Director |
1,046,203
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $39.22 per share |
41,032,081.66
|
Mar 6, 2025
| James E. Lillie Director |
5,288,734
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $39.22 per share |
207,424,147.48
|